IND candidate EPI-7386 as an N-terminal domain androgen receptor inhibitor in development for the treatment of prostate cancer-MedSci.cn

IND candidate EPI-7386 as an N-terminal domain androgen receptor inhibitor in development for the treatment of prostate cancer

Le Moigne, R; Banuelos, CA; Mawji, NR; Tam, T; Wang, J; Jian, KZ; Andersen, RJ; Cesano, A; Sadar, M; Zhou, HJ; Virsik, P

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (6):

科室
- - 订阅+
  - 更多科室
工具
服务